methionine has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergström, M; Muhr, C | 1 |
| Daemen, BJ; Doorenbos, H; Elsinga, PH; Paans, AM; Vaalburg, W; Zwertbroek, R | 1 |
| Bergström, M; Långström, B; Lundberg, PO; Muhr, C | 1 |
1 review(s) available for methionine and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
Positron emission tomography applied in the study of pituitary adenomas.
Topics: Adenoma; Amino Acids; Animals; Bromocriptine; Dopamine Antagonists; Humans; Macaca mulatta; Methionine; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiography; Receptors, Dopamine; Receptors, Dopamine D2; Tamoxifen; Tomography, Emission-Computed | 1991 |
2 other study(ies) available for methionine and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
PET studies with L-[1-11C]tyrosine, L-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment.
Topics: Adult; Bromocriptine; Carbon Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, Emission-Computed; Tyrosine | 1991 |
PET as a tool in the clinical evaluation of pituitary adenomas.
Topics: Adenoma; Carbon Radioisotopes; Diagnosis, Differential; Dopamine Antagonists; Humans; Methionine; Pituitary Neoplasms; Prolactinoma; Raclopride; Salicylamides; Tomography, Emission-Computed | 1991 |